Back to the search results

AGAPLESION BETHESDA KLINIK ULM gGmbH

Zollernring 26
89073 Ulm

Phone: 0731-187-0
Mail: ed.noiselpaga@ugb.ofni ed.noiselpaga@ugb.ofni ed.noiselpaga@ugb.ofni

https://www.bethesda-ulm.de/start

Basic information

Number of beds: 90
Number of specialist departments: 1

Number of inpatient cases: 1.524

Hospital owners: AGAPLESION gAG
Type of provider: freigemeinnützig

Academic teaching hospital

Specialist departments

Geriatrie

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	does not apply

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of the minimum quantity agreement
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
12	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
2	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
2	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Commentary on the protection concept

Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Ärztliche Anamnese

19.08.2019

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Verfahrensanweisung Medikamentenmanagement

01.11.2022

SOP on good prescription practices

Polypharmazie/Pharmakotherapie im Alter

15.05.2025

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vollständig elektronische Kurve

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Prof. Dr. med. M. Denkinger, PD Dr. med. D. Dallmeier, PD Dr. med. A. Lukas (Bonn) Prof. Dr. Kilian Rapp (Stuttgart), PD Dr. med. A. Zeyfang (Ruit) sind Dozent:innen für Geriatrie an der Universität Ulm und gestalten mit OA Dr. U. Hagg-Grün und Dr. Ch. Leinert die Lehre und Forschung des Faches Q7.

FL03 - Student training (clinical traineeship / internship year)

Explanation

Der Querschnittsbereich Q7 Medizin des alternden Menschen findet in der Klinik statt. Medizinstudent:innen können hier einen Teil ihres praktischen Jahres absolvieren, ebenso Famulaturen. Weiter sind wir an Vorlesungen im Rahmen des Seminars mit 66- Jahren und dem Querschnit Q14 (Schmerz) beteiligt.

FL04 - Project-related cooperation with colleges and universities

Explanation

Laufende Studien in 2024: SURGEAhead, Join4Joy, SFB Aging, Aqua Humana Internetseite: https://www.bethesda-ulm.de/leistungsspektrum/forschung/uebersicht"

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Laufende Studien in 2023: Zukunftstadt Ulm, TRADE, SURGEAhead, Join4Joy, SFB Aging, Prometheus Internetseite: https://www.bethesda-ulm.de/leistungsspektrum/forschung/uebersicht"

FL08 - Editors of scientific journals/textbooks

Explanation

3. Auflage "Basiswissen Medizin des Alterns und des alten Menschen". Herausgeber Hr. Dr. Dr. Zeyfang/Hr. Dr. Hagg-Grün/Hr. Prof. Dr. Denkinger; NEU ist das neue Standardwerk zur Geriatrie in DE: Bauer, J. M. Becker, C. Denkinger, M. & Wirth, R. 2024. Geriatrie. W. Kohlhammer. 978-3-17-041794-6 ISBN

FL09 - Doctoral supervision

Explanation

Prof. Dr. med. Michael Denkinger und PD Dr. med. Dhayana Dallmeier betreuen mehrere medizinische Doktorand:innen und Masterstudent:innen.

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

Prof Dr. Tim Fleiner, THU, Professur für Physiotherapie; Rebecca Scheck: Lehrbeauftragung

Training

Training in other healing professions

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Auszubildende von Berufsschulen aus der Region haben die Möglichkeit praktische Erfahrungen in unserer Klinik zu sammeln. Begleitet werden diese durch unser speziell geschultes Personal und deren Lehrkräfte.

HB06 - Occupational therapist (m/f)

Comment

Regelmäßig absolvieren Auszubildende der Ergotherapie ihre Praktika in unserem Haus und lernen somit geriatrische Therapieformen und Behandlungsmöglichkeiten kennen.

HB09 - Speech therapist (m/f)

Comment

Regelmäßig absolvieren Auszubildende der Logopädie ihre Praktika in unserem Haus und lernen somit geriatrische Therapieformen und Behandlungsmöglichkeiten kennen.

HB16 - Dietician (m/f)

Comment

Regelmäßig absolvieren Auszubildende der Diätassistenten ihre Praktika in unserem Haus und lernen somit geriatrische Therapieformen und Behandlungsmöglichkeiten kennen.

HB17 - Auxiliary nurse (m/f)

Comment

Wir bilden in Zusammenarbeit mit Pflegeschulen Krankenpflegehelfer:innen in unserem Haus aus und bieten für externe Auszubildende Praktikumsplätze an.

HB19 - Nursing professionals

Comment

Wir bilden jährlich bis zu 24 Pflegefachkräfte aus. Mit eigens freigestellten Praxisanleiter:innen, einer Pflegepuppe und einem Demoraum garantieren wir eine qualitativ hochwertige Ausbildung.

HB20 - Nursing professional B. Sc.